Corcept Therapeutics Inc. vs Abbvie Inc.
CORT vs ABBV — side-by-side comparison from reported financials. CORT leads 4, ABBV leads 7 of 11 comparable metrics.
Corcept Therapeutics Inc.
CORT · Healthcare
$121.19+2.24%Strong
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | CORT | ABBV |
|---|---|---|
| Price | $121.19 | $276.43 |
| Market cap | $13.1B | $488B |
| Revenue (TTM) | $831M | $64.4B |
| Revenue growth | +23.7% | +1.8% |
| Net margin | 6.6% | 9.8% |
| Free cash flow | $107M | $18.2B |
| Net cash (debt) | $366M | ($56.2B) |
| 1-year price return | +37.2% | +19.8% |
| P/E | 237.4 | 77.4 |
| P/E vs own history (cheap-side %) | 0% | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | 8% | 96% |
| Altman Z-score | 44.76 | 2.33 |
| CV checks passed | 8 of 10 | 9 of 10 |
| Employees | 730 | 57,000 |
Full résumé-style profiles: CORT CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.